Agios Pharm (AGIO) Peer Comparison

$33.32

$-0.96 (-2.80%)

As on 28-Aug-2026 16:00EDT

Market cap

$1,989 Mln

Revenue (TTM)

$98 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Edit

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	1,989	16,765	16,261	13,492	11,994
Revenue ($ Mln)	98	2,782	1,054	2,436	670
Net Profit ($ Mln)	-411.29	491.50	755.85	860.62	-319.95
Net Margin (%)	-418.24	17.67	71.69	35.33	-47.79
RoE (%)	-37.07	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	1.99	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	98.34	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	11.88	1,982.07	103.47	85.67	19.14
Gross Profit	42.51	760.62	588.53	2,236.43	829.45
Operating Expenses	545.49	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-459.02	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-412.30	598.92	101.11	1,035.47	-252.08
Provision for Tax	-1.02	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-411.29	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	1,026.02	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	12.19	187.89	384.48	288.55	1,362.63
Current Liabilities	70.22	1,435.43	464.70	361.93	283.35
Total Liabilities	1,297.23	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	390.76	1,006.90	895.24	1,243.41	440.60
Current Assets	717.67	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	1,297.23	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	31.17	120.10	449.89	165.93	864.07
Net Current Assets	647.45	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-372.98	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	377.18	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	8.68	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-29.16	53.56	-30.01	32.82	-0.17
ROE (%)	-37.07	110.09	163.18	42.98	-71.14
ROA (%)	-30.24	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-429.29	21.13	5.73	31.04	-0.77
Net Margin (%)	-418.24	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	140.58	24.67	114.85	9.23	12.22
EBIT Growth (%)	-160.80	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-163.27	17.50	378.76	42.89	-115.58
EPS Growth (%)	-163.46	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-27.04	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-3.85	36.06	-59.76	15.79	-2,869.63
Price / Book Value	1.33	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-1.89	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.02	0.00	0.05	0.00	0.09
Current Ratio	10.22	0.73	2.99	3.46	5.90
Quick Ratio	9.79	0.73	2.32	3.38	5.90
Interest Coverage	--	--	1.62	--	-1.72

Operating Efficiency Ratios

	Agios Pharm (AGIO)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	20.45	15.88	21.25	13.74	1.28
Asset Turnover	0.07	0.89	0.37	0.83	0.34
Receivable days	49.64	50.42	85.52	43.48	1.50
Inventory Days	959.50	--	1,056.70	96.17	--
Payable days	554.72	6.26	331.01	147.97	221.81
Cash Conversion Cycle	454.42	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly